Accelerating the Discovery, Development & Regulatory Advancement of First-in-Class, Selective, Safe & Effective Degraders & Proximity-Based Therapeutics to Unlock the Undruggable
Now in its 8th year, the TPD & Induced Proximity Summit returns as the industry’s leading meeting uniting discovery through clinical development for proximity-based modalities. Bringing together pioneers such as Arvinas, Nurix, C4 Therapeutics, emerging players like Larkspur Bio, Magnet Biomedicine, and TrimTech, plus TPD co-founders Craig Crews and Ray Deshaies, this is the premier forum to access the latest clinical insights, build strategic partnerships, and harness the vast potential of these therapies to address high unmet patient needs.
View Event
